Oxidative stress seems to be a common factor in the pathogenesis of inherited ataxias, prompting attempts to treat these conditions with antioxidants. In this Review, Massimo Pandolfo discusses the rationale for antioxidant treatment in inherited ataxias, and describes the results of the clinical trials conducted to date, focusing particularly on the use of coenzyme Q analogs to treat Friedreich ataxia.
